Benchmark dose modeling to define permissible exposure levels for environmental cadmium
Soisungwan Satarug
Journal of Environmental Exposure Assessment ›› 2025, Vol. 4 ›› Issue (3) : 28
Kidney and bone destruction in patients with itai-itai disease is caused by consuming rice contaminated with the heavy metal cadmium (Cd). Based on a lifetime intake of 2 g of Cd, and an elevation of β2-microglobulin (β2M) excretion rate, a tolerable Cd intake level was 0.83 µg/kg body weight per day (58 µg/day for a 70 kg person), with a threshold of 5.24 µg/g creatinine. However, current evidence suggests that these guidelines are inadequate to protect public health. Using experimental dosing and human population data, this review highlights the imprecision in determining exposure, internal doses, and adverse effects, leading to erroneous conclusions that Cd exposure did not diminish the estimated glomerular filtration rate (eGFR) nor did it accelerate progressive eGFR decline toward kidney failure among Cd-exposed people. It discusses the principles and application of the benchmark dose (BMD) modeling to human exposure-effect relationships from which the critical Cd exposure levels can be identified reliably, with kidney effect indicators other than the β2M excretion. It offers insights into the utility of multiple mathematical dose-response models to define the benchmark dose limit (BMDL) value for Cd exposure, which carries discernible health risk. From BMD modeling studies, Cd excretion benchmarks for early kidney effects, reflected by excretion of total proteins, N-acetyl-β-D-glucosaminidase, and eGFR decline, were 0.95, 1.34, and 3.24% of the current threshold, respectively. These Cd excretion levels are ideal for the derivation of safe Cd exposure guidelines because they are equivalent to no-observed-adverse-effect levels (NOAELs).
Benchmark dose, cadmium exposure / cadmium nephrotoxicity / NOAEL equivalent / threshold
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
Codex Alimentarius. Codex general standard for contaminants and toxins in food and feed. 2010. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.fao.org/fileadmin/user_upload/agns/pdf/CXS_193e.pdf (accessed on 2025-8-15) |
| [25] |
|
| [26] |
|
| [27] |
Joint FAO/WHO Expert Committee on Food Additives. Safety evaluation of certain food additives and contaminants. In: Joint FAO/WHO Expert Committee on Food Additives and Contaminants, Seventy-Third Meeting: Proceedings of the Joint FAO/WHO Expert Committee on Food Additives and Contaminants, Seventy-Third Meeting; 2010 Jun 8-17; Geneva, Switzerland; Geneva: 2011. Available from: https://apps.who.int/iris/handle/10665/44521 (accessed on 2025-8-15). |
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.Lancet2024;403:2204-56 PMCID:PMC11121021 |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
Cadmium and cadmium compounds.IARC Monogr Eval Carcinog Risks Hum1993; 58:119-237 PMCID:PMC7681575 |
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
Food Safety Authority (EFSA). Cadmium in food - scientific opinion of the panel on contaminants in the food chain.EFSA J2009;980:1-139 |
| [46] |
Food Safety Authority (EFSA). Statement on tolerable weekly intake for cadmium.EFSA J2011;9:1975 |
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
Committee for Recommendation of Occupational Exposure Limits, Japan Society for Occupational HealthOccupational exposure limits for acetaldehyde, 2-bromopropane, glyphosate, manganese and inorganic manganese compounds, and zinc oxide nanoparticle, and the biological exposure indices for cadmium and cadmium compounds and ethylbenzene, and carcinogenicity, occupational sensitizer, and reproductive toxicant classifications.J Occup Health2021;63:e12294 PMCID:PMC8605477 |
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
National Toxicology Program. NTP technical report on toxicity studies of cadmium oxide (CAS No. 1306–19-0) Administered by Inhalation to F344/N Rats and B6C3F1 Mice. 1995 Feb. Report No. NIH/PUB--95-3388. U.S. Department of Health and Human Services. National Institutes of Health. National Toxicology Program, Research Triangle Park, NC, USA. Available from: https://www.osti.gov/biblio/121897#:~:text=This%20report%20describes%20toxicity%20studies%20of%20cadmium%20oxide,aerosol%20in%20Sprague-Dawley%20rats%20and%20Swiss%20%28CD-1%29%20mice. (accessed on 2025-8-15). |
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
/
| 〈 |
|
〉 |